Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 43901-43950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05697250
High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy
NARecruiting
150 participants
Started: Jan 23, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05256641
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
PHASE1/PHASE2Recruiting
24 participants
Started: Jan 23, 2023 · Completed: Oct 1, 2026
4 conditions2 sponsors3 locations
NCT05425355
Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients
PHASE4Recruiting
42 participants
Started: Jan 23, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05694936
Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer
PHASE2Recruiting
90 participants
Started: Jan 23, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors11 locations
NCT05470504
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
PHASE2Recruiting
25 participants
Started: Jan 23, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT05491577
Factors Associated With an Evolution in the Quality of Life of Diabetic Patients With Chronic, Wound-free Charcot Foot
N/ARecruiting
150 participants
Started: Jan 23, 2023 · Completed: Jan 22, 2028
2 conditions1 sponsor17 locations
NCT05516069
Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.
NARecruiting
5,000 participants
Started: Jan 23, 2023 · Completed: Jun 30, 2026
5 conditions4 sponsors1 location
NCT05580562
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
PHASE3Recruiting
450 participants
Started: Jan 23, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor162 locations
NCT05733728
Retrospective Register for Uveal Melanoma
N/ARecruiting
1,400 participants
Started: Jan 23, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05962359
Neural Prediction to Enhance Language
NARecruiting
700 participants
Started: Jan 23, 2023 · Completed: Jan 23, 2028
3 conditions7 sponsors1 location
NCT05357612
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
PHASE4Recruiting
75 participants
Started: Jan 23, 2023 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT05516433
Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
N/ARecruiting
100 participants
Started: Jan 23, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05595954
Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery
N/ARecruiting
500 participants
Started: Jan 23, 2023 · Completed: Jan 31, 2026
3 conditions1 sponsor5 locations
NCT05534672
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
PHASE3Recruiting
200 participants
Started: Jan 23, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor2 locations
NCT04782258
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
PHASE3Recruiting
20 participants
Started: Jan 23, 2023 · Completed: Feb 23, 2028
1 condition1 sponsor23 locations
NCT05275972
Descemet Endothelial Thickness Comparison Trial II
PHASE3Recruiting
60 participants
Started: Jan 23, 2023 · Completed: Aug 31, 2028
3 conditions9 sponsors7 locations
NCT05489432
PREhabilitation of Candidates for REnal Transplantation
NARecruiting
128 participants
Started: Jan 23, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT05692388
Mixed-Methods Study of Multidimensional Adversity in Inner-City African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
N/ARecruiting
330 participants
Started: Jan 23, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT05539196
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
N/ARecruiting
60 participants
Started: Jan 23, 2023 · Completed: Jul 31, 2029
3 conditions1 sponsor5 locations
NCT05689762
Promotion of Healthy Lifestyle Habits in a Primary Care Setting
NARecruiting
100 participants
Started: Jan 23, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06111404
Urinary Bladder Dissection During Total Laparoscopic Hysterectomy in Cases With Previous Cesarean Section
NARecruiting
66 participants
Started: Jan 22, 2023 · Completed: Jan 18, 2025
1 condition1 sponsor1 location
NCT05921071
Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?
NARecruiting
80 participants
Started: Jan 22, 2023 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05006430
Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
PHASE1/PHASE2Recruiting
50 participants
Started: Jan 21, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05900375
Decision Aid for Parents of Infants With UPJO
NARecruiting
100 participants
Started: Jan 21, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05653271
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
PHASE1Recruiting
42 participants
Started: Jan 21, 2023 · Completed: Sep 30, 2027
8 conditions1 sponsor13 locations
NCT06301958
Dextrose Prolotherapy on Articular Cartilage
NARecruiting
60 participants
Started: Jan 21, 2023 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05693844
Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
15 participants
Started: Jan 20, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05672537
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
PHASE2Recruiting
70 participants
Started: Jan 20, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06470607
The Lymphocytic Infiltrate of Lung Tumors.
N/ARecruiting
70 participants
Started: Jan 20, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT05708274
Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
PHASE1Recruiting
28 participants
Started: Jan 20, 2023 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT06378710
Haemodynamic and Respiratory Effects of a Low Positive End Expiratory Pressure Associated With a Fluid Challenge in Knee-chest Position
NARecruiting
84 participants
Started: Jan 20, 2023 · Completed: Jan 30, 2025
1 condition1 sponsor1 location
NCT05775939
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
NARecruiting
20 participants
Started: Jan 20, 2023 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT05582239
Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults
N/ARecruiting
2,400 participants
Started: Jan 20, 2023 · Completed: Jan 20, 2026
3 conditions5 sponsors8 locations
NCT05574387
Metformin as Added on Therapy in Patients With Ulcerative Colitis
PHASE2Recruiting
46 participants
Started: Jan 20, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05565248
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
PHASE1/PHASE2Recruiting
40 participants
Started: Jan 20, 2023 · Completed: Aug 31, 2025
7 conditions2 sponsors2 locations
NCT05484622
Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma
PHASE1Recruiting
72 participants
Started: Jan 20, 2023 · Completed: Aug 30, 2027
2 conditions2 sponsors17 locations
NCT05547633
Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients with Exudative AMD (SINE)
N/ARecruiting
200 participants
Started: Jan 20, 2023 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05017311
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
PHASE4Recruiting
400 participants
Started: Jan 20, 2023 · Completed: Apr 30, 2029
1 condition12 sponsors7 locations
NCT05629611
Efficacy and Safety Evaluation of Vi-sealer
NARecruiting
280 participants
Started: Jan 20, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05614180
Chronic Total Occlusive Lesions CMR Study
N/ARecruiting
400 participants
Started: Jan 20, 2023 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT05722288
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
PHASE2Recruiting
60 participants
Started: Jan 20, 2023 · Completed: Jul 20, 2026
18 conditions2 sponsors1 location
NCT05649306
Gender Related Coping and Survivorship for Genitourinary Cancers
N/ARecruiting
80 participants
Started: Jan 20, 2023 · Completed: Sep 30, 2029
1 condition1 sponsor2 locations
NCT05651945
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
NARecruiting
150 participants
Started: Jan 20, 2023 · Completed: Jan 20, 2031
2 conditions2 sponsors1 location
NCT05731076
Self-Management Support for Lung Cancer Patients With Cachexia
NARecruiting
104 participants
Started: Jan 20, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT05679167
Digital Training Interventions for Low Back Pain
NARecruiting
90 participants
Started: Jan 20, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05327972
DEgenerative ROtator Cuff Disease and Botulinum TOXin
PHASE2Recruiting
60 participants
Started: Jan 20, 2023 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT06938750
Novel Medical Device for Pharmacological Therapy
NARecruiting
262 participants
Started: Jan 20, 2023 · Completed: Sep 20, 2026
9 conditions1 sponsor1 location
NCT05878912
The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction
NARecruiting
120 participants
Started: Jan 20, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05582200
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
N/ARecruiting
71 participants
Started: Jan 20, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05572632
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
NARecruiting
387 participants
Started: Jan 19, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors3 locations